Scaling Human Ingenuity: Pandorum Technologies Secures $18 Million to Revolutionize Global Regenerative Medicine
What is the news?
Pandorum Technologies, a visionary deep-tech startup founded by Indian-origin entrepreneurs Arun Chandru and Tuhin Bhowmick, has announced a significant milestone with a fresh $18 million (INR 150 Crore) funding round. Based in Bengaluru but operating with a global vision, Pandorum is dedicated to designing and manufacturing functional human tissues, such as bio-engineered corneas and lung tissues. This capital injection, led by Kotak Alternate Assets and other strategic investors, marks a pivotal moment for the company as it transitions into high-stakes clinical phases.
Why is it interesting?
The success of Pandorum Technologies underscores the rising prominence of the “Global Indian Alpha” founders who are leveraging India’s immense intellectual capital to solve some of the world’s most pressing medical challenges. By developing “Liquid Cornea” to treat corneal blindness and advanced cell-based therapies for lung health, the company is positioning itself as a global leader in biotechnology. The funding will specifically enable Pandorum to accelerate its research and development, scale its manufacturing capabilities, and move closer to making bio-engineered organs a reality for patients worldwide.
Read more: Indian biotech startup Pandorum Technologies raises $18 million in funding to scale operations